Elicio TherapeuticsELTX
13F holders, Q2 2024 (June 30)20holders +2
5new positions
3sold out
$4.13avg. 13F price*
At the end of Q2 2024, 20 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, up 2 from Q1 2024. 5 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($930K), Armistice Capital, LLC ($411K) and Geode Capital Management, LLC ($294K).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $911K |
| Exits | 3 | $92K |
All 13F filers, Q1 2024 → Q2 2024: 279,449 shares bought and 37,161 shares sold, net +242,288 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | Add +4.9% | 226,297 | $930K |
| Armistice Capital, LLC | 0.01% | New | 100,000 | $411K |
| Geode Capital Management, LLC | 0.00% | Add +49.9% | 71,508 | $294K |
| Arena Investors LP | 10.82% | New | 50,000 | $206K |
| CM Management, LLC | 0.19% | Reduce -33.3% | 50,000 | $206K |
| Hudson Bay Capital Management LP | 0.00% | New | 48,720 | $200K |
| State Street Corp. | 0.00% | Add +24.4% | 21,900 | $90K |
| BlackRock Inc. | 0.00% | Add +1970.3% | 18,985 | $78K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $57K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 12,500 | $51K |
| Warberg Asset Management LLC | 0.23% | New | 11,801 | $49K |
| Northern Trust Corp. | 0.00% | New | 11,180 | $46K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 7,000 | $43K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,554 | $6K |
| National Bank of Canada | 0.00% | Add +114.3% | 1,500 | $6K |
| Bank of America Corp. | 0.00% | Add +4.9% | 1,202 | $5K |
| Citigroup Inc. | 0.00% | No change | 374 | $2K |
| Morgan Stanley | 0.00% | Add +76.9% | 230 | $945 |
| UBS Group AG | 0.00% | Add +6.3% | 17 | $70 |
| Avion Wealth | 0.00% | No change | 78 | $0 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.